Evidence map›Paper›PMID 32371573›Full record

ArticleBMJ global health2020

Diagnostic performance of a point-of-care saliva urea nitrogen dipstick to screen for kidney disease in low-resource settings where serum creatinine is unavailable.

Rhys D R Evans, Ulla Hemmila, Henry Mzinganjira, Mwayi Mtekateka, Enos Banda, Naomi Sibale, Zuze Kawale, Chimota Phiri, Gavin Dreyer, Viviane Calice-Silva and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. BUN level is associated with cancer prevalence.European journal of medical research · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 4 countries.

Rhys D R EvansRenal Medicine, University College London, London, UK rhys.evans@ucl.ac.uk.ORCID 0000-0001-7543-2041
Ulla HemmilaRenal Medicine, Barts Health NHS Trust, London, London, UK.
Henry MzinganjiraRenal Medicine, Queen Elizabeth Central Hospital, Blantyre, Southern Region, Malawi.
Mwayi MtekatekaRenal Medicine, Queen Elizabeth Central Hospital, Blantyre, Southern Region, Malawi.
Enos BandaRenal Medicine, Queen Elizabeth Central Hospital, Blantyre, Southern Region, Malawi.
Naomi SibaleRenal Medicine, Queen Elizabeth Central Hospital, Blantyre, Southern Region, Malawi.
Zuze KawaleRenal Medicine, Queen Elizabeth Central Hospital, Blantyre, Southern Region, Malawi.
Chimota PhiriRenal Medicine, Queen Elizabeth Central Hospital, Blantyre, Southern Region, Malawi.
Gavin DreyerRenal Medicine, Barts Health NHS Trust, London, London, UK.
Viviane Calice-SilvaRenal Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil.
Jochen G RaimannRenal Research Institute, New York, New York, USA.ORCID 0000-0002-8954-2783
Nathan LevinMedicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Roberto Pecoits-FilhoArbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
Ravi MehtaMedicine, University of California San Diego, La Jolla, California, USA.
Etienne MacedoMedicine, University of California San Diego, La Jolla, California, USA.
Queen Elizabeth Central Hospital · MWBarts Health NHS Trust · GBUniversity of California San Diego · USArbor Research Collaborative for Health · USIcahn School of Medicine at Mount Sinai · USPontifícia Universidade Católica do Paraná · BRRenal Research Institute · USUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKidney disease is prevalent in low-resource settings worldwide, but tests for its diagnosis are often unavailable. The saliva urea nitrogen (SUN) dipstick is a laboratory and electricity independent tool, which may be used for the detection of kidney disease. We investigated the feasibility and performance of its use in diagnosing kidney disease in community settings in Africa.

methodsAdult patients at increased risk of kidney disease presenting to three community health centres, a rural district hospital and a central hospital in Malawi were recruited between October 2016 and September 2017. Patients underwent concurrent SUN and creatinine testing at enrolment, and at 1 week, 1 month, 3 months and 6 months thereafter.

resultsOf 710 patients who presented at increased risk of kidney disease, 655 (92.3%) underwent SUN testing at enrolment, and were included (aged 38 (29-52) years, 367 (56%) female and 333 (50.8%) with HIV). Kidney disease was present in 482 (73.6%) patients and 1479 SUN measurements were made overall. Estimated glomerular filtration rate (eGFR) correlated with SUN (r=-0.39; p<0.0001). The area under the receiver operating characteristics curve was 0.61 for presenting SUN to detect acute or chronic kidney disease, and 0.87 to detect severe (eGFR <15 mL/min/1.73 m

conclusionsSUN, measured by dipstick, is feasible and may be used to screen for kidney disease in low resource settings where creatinine tests are unavailable.

Indexed as

Kidney DiseasesSalivaAdultAfricaCreatinineFemaleHumansNitrogenPoint-of-Care SystemsUreaCreatinineNitrogenUreahealth systemsHIVother diagnostic or toolprevention strategiesscreening

Identifiers

PMID32371573
PMCPMC7228485
OpenAlexW3021745578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.